KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $3.2 billion.

  • Amgen's Net Income towards Common Stockholders rose 1363.96% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 6560.28%. This contributed to the annual value of $4.1 billion for FY2024, which is 3910.97% down from last year.
  • Latest data reveals that Amgen reported Net Income towards Common Stockholders of $3.2 billion as of Q3 2025, which was up 1363.96% from $1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Amgen's Net Income towards Common Stockholders peaked at $3.2 billion during Q3 2025, and registered a low of -$113.0 million during Q1 2024.
  • For the 5-year period, Amgen's Net Income towards Common Stockholders averaged around $1.6 billion, with its median value being $1.6 billion (2022).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first tumbled by 10397.75% in 2024, then soared by 163097.35% in 2025.
  • Quarter analysis of 5 years shows Amgen's Net Income towards Common Stockholders stood at $1.9 billion in 2021, then decreased by 14.9% to $1.6 billion in 2022, then plummeted by 52.54% to $767.0 million in 2023, then fell by 18.25% to $627.0 million in 2024, then surged by 412.92% to $3.2 billion in 2025.
  • Its Net Income towards Common Stockholders stands at $3.2 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.7 billion for Q1 2025.